Cite
Costell MH, Ancellin N, Bernard RE, et al. Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress. Front Pharmacol. 2012;3:128doi: 10.3389/fphar.2012.00128.
Costell, M. H., Ancellin, N., Bernard, R. E., Zhao, S., Upson, J. J., Morgan, L. A., Maniscalco, K., Olzinski, A. R., Ballard, V. L., Herry, K., Grondin, P., Dodic, N., Mirguet, O., Bouillot, A., Gellibert, F., Coatney, R. W., Lepore, J. J., Jucker, B. M., Jolivette, L. J., Willette, R. N., Schnackenberg, C. G., & Behm, D. J. (2012). Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress. Frontiers in pharmacology, 3128. https://doi.org/10.3389/fphar.2012.00128
Costell, Melissa H, et al. "Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress." Frontiers in pharmacology vol. 3 (2012): 128. doi: https://doi.org/10.3389/fphar.2012.00128
Costell MH, Ancellin N, Bernard RE, Zhao S, Upson JJ, Morgan LA, Maniscalco K, Olzinski AR, Ballard VL, Herry K, Grondin P, Dodic N, Mirguet O, Bouillot A, Gellibert F, Coatney RW, Lepore JJ, Jucker BM, Jolivette LJ, Willette RN, Schnackenberg CG, Behm DJ. Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress. Front Pharmacol. 2012 Jul 05;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. PMID: 22783192; PMCID: PMC3389674.
Copy
Download .nbib